Covered recipient · General Payments record
ABBAS MEHDI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$28,744.80
- Reported across 423 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,063.98 | 99 |
| Education | $1.25 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $251.47 | 15 |
| Celgene Corporation | $224.03 | 12 |
| Genentech USA, Inc. | $171.72 | 8 |
| EMD Serono, Inc. | $166.62 | 8 |
| SK Life Science, Inc. | $162.97 | 8 |
| ARGENX US, INC. | $156.16 | 10 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $147.02 | 6 |
| Alexion Pharmaceuticals, Inc. | $146.58 | 6 |
| Neurelis, Inc. | $103.17 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $76.05 | 3 |
| NEUROPACE, INC. | $68.27 | 2 |
| Amgen Inc. | $61.05 | 3 |
| Grifols USA, LLC | $51.43 | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $42.17 | 2 |
| UCB, Inc. | $33.39 | 1 |
| Otsuka America Pharmaceutical, Inc. | $26.41 | 1 |
| EISAI INC. | $24.45 | 1 |
| Lilly USA, LLC | $24.06 | 1 |
| Sumitomo Pharma America, Inc. | $22.59 | 1 |
| PFIZER INC. | $21.64 | 1 |
| LivaNova USA, Inc. | $19.05 | 1 |
| MDD US Operations, LLC | $17.33 | 1 |
| Octapharma USA, Inc. | $16.92 | 1 |
| Biogen, Inc. | $16.43 | 1 |
| Amneal Pharmaceuticals LLC | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (100)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.